Dynavax begins clinical trial for new shingles vaccine candidate, Z-1018
Dynavax Technologies Corporation, a renowned player in the biopharmaceutical sector, has made headlines with the initiation of a Phase 1/2 clinical trial for its innovative ... Read More
BioNTech and Pfizer forge $425m partnership to develop mRNA-based flu vaccines
In a significant advancement in vaccine research, German biotech firm BioNTech has partnered with American pharmaceutical giant Pfizer in a multi-year research and development collaboration ... Read More